Board Approved shifting of registered office from the state of Gujarat to Maharashtra, subject to the approval of the shareholders at ensuing AGM
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
At its meeting on September 3, 2025, the board of ZR2 Bioenergy (formerly Gujchem Distillers India) approved several items pending shareholder approval at the 86th AGM. The board recommended a final dividend of Rs. 0.10 per equity share (10%) for FY ended March 31, 2025, with September 9, 2025 set as the record date. It also approved shifting the registered office from Gujarat to Maharashtra and amending the Memorandum of Association accordingly. Additionally, the board approved a new Employee Stock Option Plan ('ZR2 Bioenergy ESOP 2025') and reclassified the authorised capital — keeping it at Rs. 10 crore but converting it entirely into 10 crore equity shares of Rs. 1 each (removing preference and unclassified shares). M/s Ritika Agarwal & Associates was appointed as Secretarial Auditor for five years (FY2025-26 to FY2029-30), and Mr. Nilesh Jayant Jain was recommended for re-appointment as a director.
The 10% dividend is modest but signals continuity in shareholder returns. The shift of registered office to Maharashtra aligns the company with its existing corporate office in Mumbai and may improve operational and regulatory convenience. The ESOP 2025 and capital reclassification position the company for potential future fund-raising or share issuance, which could dilute existing shareholders if stock options are eventually exercised.